Promising New Drug Candidate Shows Potential to Prevent Preterm Birth in Preclinical Trials
A groundbreaking advancement in the fight against preterm birth has emerged from recent preclinical studies involving a novel anti-inflammatory drug candidate named Rytvela. This research,...














